The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
Astec LifeSciences Limited is an India-based company, which is engaged in the manufacturing of agrochemical active ingredients (technical), bulk, formulations and intermediate products. The Company undertakes contract development and manufacturing services for a diverse range…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A weak business.
Astec Lifesciences is scored on the general / industrial framework. It keeps a thin -17.9% of every rupee of sales as net profit. Free cash flow is worth about -6.8% of its market value.
Net worth has actually shrunk (-2%/yr) — value is not being built. Return on equity is a weak -23.8%.
It trades at -16× earnings. The books come through clean — a forensic grade of A, and Altman puts distress risk in the safe zone.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | -15.69 | 24.55 | better |
| P/B | 3.73 | 2.05 | worse |
| EV/EBITDA | — | — | — |
| ROE | -23.77 | 3.96 | worse |
| ROCE | -7.49 | 9.3 | worse |
| ROA | -10.01 | 4.18 | worse |
| Quick Ratio | 0.61 | 1.76 | worse |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| UPL | 20.9 | 1.3 | 5.4% |
| PI Industries | 30.0 | 2.3 | 7.7% |
| Sumitomo Chemical India | 29.3 | 4.4 | 15.1% |
Negative CAGR — the top line has shrunk over this window. Growth is accelerating — latest year outpaced the prior year's rate.
3 of the 4 years shown had a loss — profitability is inconsistent. The latest year saw a +40% swing — check if it's a one-off or structural.
Operating margin has compressed from 5% to -18% — costs or competition are eating into profitability. Margins have declined for 2 consecutive years — watch for a structural cost problem.
Negative ROE — the business is destroying shareholder value. Capital efficiency declining — ROE down 27pp.
2 of 4 years had negative operating cash flow — profitability on paper may not translate to cash. Investing outflows exceed operating cash — the company relies on external funding to finance expansion.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue fell 14% QoQ — could be seasonality or a genuine slowdown. Wide quarterly swings (55% spread) — likely seasonality, lumpy orders, or project-based revenue. Run-rate fading — recent quarters 45% below earlier ones.
4 of 4 quarters loss-making — quarterly profitability is uneven. Profit fell 100% QoQ — one-quarter drops can be noise, but a pattern matters. Quarterly margins are compressing (-12% → -51%) — more revenue isn't translating to proportionally more profit.
P/E band unavailable — needs 5y of consistent EPS + price history.
Promoters hold 72.0% — heavily owner-operated with strong skin in the game.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.